全球血液蛋白及造血劑市場：策略分析與未來預測

Abstract

This report analyzes the worldwide markets for Blood Banking & Blood Products in Millions of US$. The specific product segments analyzed are Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 144 companies including many key and niche players worldwide such as America' s Blood Centers, AABB, American Red Cross, CorCell Inc., Japan Red Cross, LifeBank Cryogenics, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, The Cord Blood Registry, VITA 34 AG, Beckman Coulter Inc, Becton Dickinson, Bio Products Laboratory, Chiron Corporation, CSL Behring, Daxor Corporation, Fresenius Group, Gambro BCT, Gen-Probe Incorporated, Grifols, Haemonetics, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Blood Components and Plasma Products
• Whole Blood & Cellular Components
• WBCs
• RBCs
• Platelets
• Plasma Fractions
• Fresh Frozen Plasma
• Albumin Fractions
• Factor VIII
• Factor IX and Factor IX Complex
• Fibrin/Thrombin
• Equipment, Blood Tests and Consumables
• Automated Analyzers for Blood Analysis
• Blood Tests
• Consumables

II. EXECUTIVE SUMMARY

1. Market Overview

• Healthcare Scares Propel the Market
• Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
• Worldwide Blood Banking and Blood Products Market at a Glance
• Current & Future Analysis
• Analysis by Geographic Region
• Analysis by Product Segment
• World Blood Components and Plasma Market Analysis in Units
• Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
• Red Blood Cells - A Key Blood Component and a Major Contributor
• Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)

2. Market Trends & Issues

• New Infections - A Continuous Threat...
• Safety and Availability: The Core Issues
• Decontamination: A Viable Process
• New Processes for Safer Blood Supply
• Innovative Procedures Help Blood Conservation
• Autologous Transfusion Strapping up for High Growth
• Enzyme Converted Cells Set to Rule the Industry
• Blood Unavailability: Substitutes to the Rescue
• Transfusions: Hospitals Making Way for Others
• Computer Identification Helps Patients
• SARS: A Case of Mistaken Identity?
• Pooling: Economical HIV Testing
• Private Cord Blood Banking: Flying High Despite Opposition
• Automation of Blood Banking - Nearing the Efficiency Frontier?
• Automated Instrumentation Taking the Front Seat
• Table 5: World Market for Blood Bank Technology (2004): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation(includes corresponding Graph/Chart)
• Table 6: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart)
• Plasma Market: Automation Making Inroads
• The RBC Market - Slow to Catch Up
• Automation of Testing - Yet to Mature
• Automation to Suffice Shortage Problems
• How Near to the Efficiency Frontier?

3. Product Overview

• Blood Banking and Blood Products Industry
• Blood Components and Plasma Products
• Equipment, Blood Tests and Consumables
• Automated Analyzers for Blood Analysis
• Blood Tests
• Consumables
• Blood - A Primer
• Ionic Structure
• Blood Components and their Applications
• Blood Constituents
• Plasma
• Table 7: World Recent Past, Current & Future Analysis for Plasma Products - Annual Sales Figures in US$ Million for Years 2003 through 2010 (includes corresponding Graph/Chart)
• Red Blood Cells (RBC)
• Blood Count
• Platelets
• White Blood Cells (WBC)
• Derivative Products of Blood or Plasma Fractions
• Plasma Protein and Fractionation
• The Need
• Fresh Frozen Plasma
• Other Plasma Fractions
• Albumin Fractions
• Albumin Usage Rising in Profile, Wastage Worries Run Deep
• Factor VIII
• Factor IX and Factor IX Complex
• Fibrin/Thrombin
• Consumption of Blood Based on Type of Surgery/ Accident (In Units)
• Table 8: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region/Country - USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
• Table 9: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Product Type - IVIG, Factor VIII, Albumin, Alpha-1, Fibrin, Factor IX, AT III, and Others (includes corresponding Graph/Chart)

4. Blood Collection Methods

• Banking the Natural Blood Resources
• Blood Banks
• Blood Banking
• Blood Transfusion
• Role of Blood Banks
• Blood Donor: The Epicenter of the Process
• Eligibility Criteria for the Donor
• The Basics of Blood Donation - Myths Exploded & Other Facts
• Collection Methods
• Blood Donation: The Process
• Types of Blood Donation
• Directed Blood Donations
• Autologous Blood Donation
• Alternative Usage of Patient' s Own Blood
• General Blood Donation
• Hemodilution
• Wound Drainage
• Cell Saver
• The Method
• Blood Salvaging
• Blood Collection Centers
• Blood Collection Management System
• A Historical Retrospective
• Blood Collection Centers
• Types of Blood Collection Centers
• Cord Blood Banks
• Profit Collection Centers
• Military Blood Banks
• Hospital Blood Banks
• Community Blood Banks
• Non-Profit Collection Centers
• Blood Processing
• Blood Typing
• Rh Blood Group System
• ABO Blood Group System
• Blood Types and their Compatibility
• Table 10: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)
• Blood Test
• Blood Culture
• The Costs

5. The Changing Landscape of Transfusion Technologies & Tests

• Blood Transfusion: A Backdrop
• Massive Transfusion
• Complications and Risks Due to Transfusion
• Circulatory Overload
• Graft Versus Host Disease (GVHD)
• Haemolytic Transfusion Reactions
• Iron Overload
• Bacterial Contamination
• Thrombophlebitis
• Allergic Reactions
• Air Embolism
• Hyperkalaemia
• Changing Role of Blood Banking Technology

6. Blood Transfusion: The Process,Tests/Technologies

• Cross Matching
• Blood Donor/Recipient Screening
• Blood Typing
• Leukoreduction
• Leukocyte Reduction Specification Standards/Filters
• Coombs Test

7. Alternatives to Blood Transfusion: A Real Threat to the Industry

• Bloodless Surgery
• Therapeutic Apheresis
• Plasmapheresis
• Plateletpheresis
• Leukapheresis
• Volume Expanders
• Colloids
• Albumin
• Dextrans
• Hydroxyethyl Starch
• Crystalloids
• Blood Growth Factor Therapies - Newer Alternatives to Transfusion

8. Blood Substitutes

• Blood Substitutes Under Development by Manufacturers
• Synthetic Blood Manufacturers/Developers
• Alliance Pharmaceuticals Corp. (USA)
• Biopure Corporation (USA)
• Enzon Pharmaceuticals (USA)
• Hemosol Inc. (Canada)
• Northfield Laboratories Inc. (USA)
• Synthetic Blood International, Inc. (USA)

9. Product Introductions/Innovations

• Pall Unveils Acrodose(tm) PLus System
• Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market
• Dade Behring Launches the Quadriga BeFree System
• Swedish Inventors Develop New Processing System
• Canada Invents New Method for Monitoring Blood and Blood Products
• Terumo Launches Improvised Bags For Safe Blood Collection
• Haemonetics Launches Cymbal Automated Blood Collection System
• Illinois Inventors Introduces New Systems to Prepare Blood Products
• Abbott Unveils Two New Products for Blood Banks
• Cell Robotics Introduces New Lasette P 200
• Beckman' s COULTER(r) LH 750 Hematology Analyzers Hit the Market
• Haemonetics Unveils MCS(r)+ - Improved Red Cell Collection Technology
• Baxter Launches ALYX Component Collection System
• Grifols' DG Gel(r) Revolutionizes Column Agglutination
• BioMerieux Introduces DAVINCI(r)...
• Pall Develops Novel Blood Filtration Membrane

10. Products in Pipeline & Technology Update

• From Clinical Trials to Clinics
• Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets
• Haemonetics Wins FDA Approval for the ACP 215 System
• Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance
• Pall' s eBDS Receives Green Signal from FDA
• CardioPAT(tm) Surgical Blood Salvage System
• PCS(r) 2 - Set to Enhance Plasma Quality
• Dade Behring' s D-Dimer Assay Strapping up for Roll Out

11. Recent Industry Activity

• ZymoGenetics Obtains FDA Approval for Marketing Recothrom
• CellaVision Enters into a Two-Year Manufacturing Agreement with Kitron AB
• PerkinElmer Completes ViaCell Acquisition
• Texas Cord Blood Bank Expands Cord Blood Collection Network
• Inverness Medical Acquires HemoSense
• Haemonetics Acquires Haemoscope' Hemostasis Analyzer Business Unit
• NxStage Medical Completes Medisystems Acquisition
• CordLife Establishes Cord Blood Bank in Indonesia
• Xinjiang Deyuan Begins Construction of a New Blood Product Plant
• Cord Blood America Acquires Curesource
• Grifols and Cerus Join Hands to Commercialize Cerus' Intercept Blood System
• SFDA Revokes Drug Approval and Production Permit of Guangdong Bioyee
• Immucor Obtains Clearance from FDA for Marketing Galileo Echo
• Cryobanks to Set Up a Cord Blood Bank in Thailand
• Grifols to Manage Four New Plasma Collection Centers in US
• Hualan Biological Acquires Chongqing Yituo
• CyGenics to Focus on Cord Blood Banking
• Cord Blood America Acquires CorCell
• Stemcyte to Establish Cord Blood Bank in India
• Baxter Divests Transfusion Therapies Business
• Cerus Obtains Approval for Intercept Blood System in Germany
• Cangene Obtains Health Canada Approval for Anti-Hepatitis B Blood Product
• Cord Blood America Inks Marketing Agreement with MSBCBS
• BCCL Acquires Stake in Life Cell
• SunTech Medical Group Acquires Empirical Technologies
• Cord Blood America Acquires Cryobank
• Kalbe Acquires Stake in CyGenics' s Subsidiary CordLife Indonesia
• Cryobanks International Signs Letters of Intent with MedStem Services
• Cryobanks International Opens Cord Blood Stem Cell Bank
• DomaniCell Initiates Family Cord Blood Banking Program in Hospitals
• Cryobanks International Grants License for Cord Blood Processing System
• Community Blood Center Bags Contract
• Wilkes Medical Center Grants License for SafeTrace Tx
• Biosite Collaborates with HUG Research Hospital
• Pliva Terminates Agreement with Mayne
• Mississippi Blood Services Secures Contract
• APL Partners with Omscan
• DomaniCell Receives Stem Cell Banking License
• ThermoGenesis Enters into an Agreement with Cord Blood Registry
• ZLB Enters into Plasma Deal with BCA
• ViaCell and Pall Secure FDA Approval for ViaCord(r) Collection Kit
• Pall Secures Contract from NBS to Supply ' Leukotrap' Filtration System
• Biotest and Sanquin to Form Joint Venture for Plasma Production
• Consorta Signs Partnership Agreement with GSABC
• Haemonetics Signs Supply Agreement with Canadian Blood Services
• Haemonetics Extends the Agreement with American Red Cross
• Novation and Abbott Enter into a Technology Agreement
• Olympus Redefines the Agreement with Biotest
• Cerus to Receive Marketing Rights over Baxter' s INTERCEPT Blood System
• CyGenics to Establish a New Cord Blood Banking Company
• UKCBB to Establish a Modern Laboratory in UMIC' s New CTF
• St. John' s Medical Center Procures Wyndgate' s SafeTrace Tx
• Florida`s Blood Centers Acquires South Florida Blood Banks
• BioStem Takes Over Cryobanks International
• FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public Donation Option
• Pall Signs Sale Agreement with Green Cross for Blood Filters
• TCBB Starts Collecting Donations for Cord Blood
• Pall Received FDA Clearance to Market New Pall Acrodose(tm) PL System
• CordLife Singapore Receives AABB Accreditation
• ITL and ARC Enter into an Agreement for Blood Bank Equipment
• NBA and UKT Merge to Form NHSBT
• BioMerieux and ExonHit Extend Collaboration to Develop Blood Diagnostics
• Wyndgate Signs Agreement with Cameron Hospital
• Daxor' s Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers
• Baxter and American Red Cross Enter Into Agreement
• CSL Signs Agreement with National Blood Authority
• Chiron Finds a South African Partner for Procleix(r) Tigris(r)
• ThermoGenesis and BHHTI Jointly Market CryoSeal FS
• Baxter and Cerus Enter into a Marketing Agreement
• Haemonetics Signs Technology Alliance with ZLB Plasma Services
• BioTime Collaborates with Summit Pharmaceuticals International Corp.
• SurgiLance Bags a Contract from America' s Blood Centers
• Florida' s Blood Centers Acquire Lake Park-based South Florida Blood Banks
• Global Med Technologies' Division Signs Agreement with Hospital Partners of America
• Radiometer America and Consorta Extend Blood-Gas Products Deal
• Baxter' s ALYX System Wins Medical Design Excellence Award
• Terumo Corp. Ups Stake in Blood Bag Venture
• Vita 34 International AG Takes over the Holdings of Corcell and Vita 34
• CSL Acquires Aventis Behring
• Medsurge Medical Products Corp. Buys Cryo Genomics
• Haemonetics' Acquisition of Harvest Technologies Expands Surgical Blood Salvage Portfolio
• Chiron Buys Prion Solutions
• Celmed & Gambro Tie up for GvHD Prevention System
• Chiron Grants NAT Licenses to LabCorp and German Red Cross
• Sekisui Chemical Ventures into Chinese Blood Collection Market
• Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer
• PRDT, ARC & Maco Pharma in a Strategic Alliance
• Pall' s Enhanced Bacterial Detection System to be Marketed by Kawasumi
• Baxter and Cerus Rope in Bioone Corp for Marketing Intercept
• Chiron Partners with ZymeQuest
• Pall Corporation Signs Agreement with Haemonetics Corporation
• Haemonetics Corporation & Hemosystem SA in a Marketing Alliance
• Chiron' s Armor Strengthened with Infectio' s Rapid Bacterial Detection Licenses
• Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver(r) 5
• Haemonetics Obtains Marketing Licenses for Crit Scan(r)
• Lifebank Receives AABB Accreditation
• Bayer Divests Plasma Products Business to NPS
• ITL Receives FDA Clearance to Market SSK
• Chronix Biomedical Files Patent Approval for a New Diagnostic Test
• ViaCell' s Selective Amplification(tm) Program Boosts Cord Blood Banks' Productivity
• CordLife Opens Second Cord Blood Banking Facility Singapore
• PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation Technologies
• Novation Bags Big Ticket Deals for Blood Products

12. Focus on Select Global Players

• Leading Blood Banks
• America' s Blood Centers (USA)
• AABB (USA)
• American Red Cross (USA)
• CorCell Inc. (USA)
• Japan Red Cross (Japan)
• LifeBank Cryogenics (Canada)
• National Blood Foundation (USA)
• New England Cord Blood Bank, Inc. (USA)
• New York Blood Center (USA)
• The Cord Blood Registry (USA)
• VITA 34 AG (Germany)
• Leading Players in Blood Bank Technology & Supplies
• Beckman Coulter Inc (USA)
• Becton Dickinson (USA)
• Bio Products Laboratory (UK)
• Chiron Corporation (USA)
• CSL Behring (USA)
• Daxor Corporation (USA)
• Fresenius Group (Germany)
• Gambro BCT (US)
• Gen-Probe Incorporated (USA)
• Grifols (Spain)
• Haemonetics (USA)
• Hemagen Diagnostics Inc. (USA)
• Immucor Inc. (USA)
• Kawasumi Laboratories, Inc. (Japan)
• Olympus America, Inc. (USA)
• PharmaStem Therapeutics, Inc. (USA)
• Terumo Corporation (Japan)
• ThermoGenesis Corp. (USA)
• ZymeQuest, Inc. (USA)

13. Global Market Perspective

• Table 11: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 12: World Long-term Projections for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 13: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 14: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 15: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 16: World Long-term Projections for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 17: World Historic Review for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 18: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 19: World Long-term Projections for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 20: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 21: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 22: World 15-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1998, 2008 & 2012
• Table 23: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 24: World Long-term Projections for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 25: World Historic Review for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 26: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 27: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 28: World Long-term Projections for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 29: World Historic Review for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 30: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 31: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 32: World Long-term Projections for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 33: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 34: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • Market Trends
  • US Blood Collection & Supply Profile
  • Blood Group Distribution
  • Table 35: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)
  • Table 36: Percentage Break up of Rh Blood Types in the US by Racial Group
  • Blood Donated and Transfused Every Year
  • Males Form the Major Chunk of Donors
  • Cost of Blood
  • SARS Scares: Blood Banks Feel the Heat
  • Whole Human Blood: Export-Import Scenario in the Recent Past
  • Table 37: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Exports by Country - France, Canada, UK, Germany, Japan, Taiwan, Korea, Belgium, Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart)
  • Table 38: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Value Exports by Country - France, UK, Germany, Japan, Canada, Belgium, Korea, Peru, Taiwan, Netherlands, Italy, and Others (includes corresponding Graph/Chart)
  • Table 39: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Consumption of Volume Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
  • Table 40: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Consumption of Value Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
  • US Blood Components and Plasma Market Analysis in Units
  • Table 41: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 42: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
  • Product Launches/Developments
  • Strategic Corporate Developments
  • Key Players
  • Blood Banks
  • America' s Blood Centers
  • AABB
  • American Red Cross
  • Blood Bank of Alaska
  • California Cryobank
  • Community Blood Bank
  • CorCell Inc.
  • National Blood Foundation
  • New England Cord Blood Bank, Inc.
  • New York Blood Center
  • Oklahoma Blood Institute
  • The Cord Blood Registry
  • Blood Bank Technology Developers and Consumables Suppliers
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Chiron Corporation
  • CSL Behring (USA)
  • Daxor Corporation
  • Gen-Probe Incorporated
  • Gambro BCT
  • Haemonetics
  • Hemagen Diagnostics Inc.
  • Immucor Inc.
  • Olympus America, Inc.
  • PharmaStem Therapeutics, Inc.
  • ThermoGenesis Corp.
  • ViaCell, Inc.
  • ZymeQuest, Inc.
• B. Market Analytics
  • Table 43: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 44: US Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 45: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 46: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Current and Future Analysis
  • The ' CSA-Z 902-04' - A Comprehensive Voluntary Blood Safety Standard
  • LifeBank Cryogenics - The Only AABB Accredited Cord blood Stem Cell Bank
  • Product Launches/Developments
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 47: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 48: Canadian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 49: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 50: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Current and Future Analysis
  • Growing Market for Fresh Frozen Plasma
  • Strategic Corporate Developments
  • Key Players
  • Japan Red Cross
  • Kawasumi Laboratories, Inc.
  • Terumo Corporation
• B. Market Analytics
  • Table 51: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 52: Japanese Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 53: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 54: Japanese 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

• A. Market Analysis
  • Current & Future Analysis
  • Analysis by Geographic Region
  • European Blood Banking and Blood Products Market at a Glance (All figures are 2008 estimates & CAGR is for the period 2001-2010)
  • Analysis by Product Segment
  • Market Trends and Issues
  • Legislations on Payment for Donation Restrict Donors
  • Government' s Check on Healthcare Costs Pressurizes BCT Manufacturers
  • Purchasing System Witnesses Modifications
  • EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products
  • A Snapshot of Health Care Systems Across Select EU Countries
  • France
  • Germany
  • Italy
  • The UK
  • Spain
  • Product Launches/Developments
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 55: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 56: European Long-term Projections for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 57: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 58: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 59: European Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 60: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 61: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 62: European 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 63: Leading Players in the French Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart)
• B. Market Analytics
  • Table 64: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 65: French Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 66: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 67: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 68: Leading Players in the German Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart)
  • Key Players
  • Fresenius Group
  • VITA 34 AG
• B. Market Analytics
  • Table 69: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 70: German Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 71: German Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 72: German 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

• Market Analysis
• Current and Future Analysis
• Table 73: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 74: Italian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 75: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 76: Italian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 77: Leading Players in the UK Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown of Revenues for Bio Products Laboratory, Baxter, Grifols, and Others (includes corresponding Graph/Chart)
  • Key Player
  • Bio Products Laboratory
  • Surgical Innovation Group Plc
• B. Market Analytics
  • Table 78: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding raph/Chart)
  • Table 79: UK Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 80: UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 81: UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Spain

• A. Market Analysis
  • Current and Future Analysis
  • Competitive Scenario
  • Table 82: Leading Players in the Spanish Blood Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Baxter, Grifols, ZLB Behring, and Others (includes corresponding Graph/Chart)
  • Strategic Corporate Development
  • Key Player
  • Grifols
• B. Market Analytics
  • Table 83: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding raph/Chart)
  • Table 84: Spanish Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 85: Spanish Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 86: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4f. Russia

• Market Analysis
• Current and Future Analysis
• Table 87: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 88: Russian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 89: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 90: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

4g. Rest of Europe

• A. Market Analysis
  • Current and Future Analysis
  • Strategic Corporate Developments
• B. Market Analytics
  • Table 91: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 92: Rest of Europe Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 93: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 94: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Current and Future Analysis
  • ASEAN - Striding Towards Standardization of Blood Supply
  • China - A Key Market
  • Government Wakes Up to Realities
  • Table 95: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
  • Table 96: Chinese Market for Blood Banking & Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female
  • Table 97: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart)
  • Strategic Corporate Developments
  • Key Players
  • Indian Red Cross Society (India)
• B. Market Analytics
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 99: Asia-Pacific Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 100: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 101: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

6. Latin America

• Market Analysis
• Current and Future Analysis
• Table 102: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 103: Latin American Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 104: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 105: Latin American 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)

7. Rest of World

• Market Analysis
• Current and Future Analysis
• Table 106: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
• Table 107: Rest of World Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 108: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
• Table 109: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)